athenahealth, Inc. (NASDAQ:ATHN) – Research analysts at SunTrust Banks lifted their FY2017 earnings per share estimates for athenahealth in a research note issued on Wednesday, according to Zacks Investment Research. SunTrust Banks analyst S. Draper now anticipates that the health services provider will post earnings per share of $1.18 for the year, up from their previous estimate of $0.97. SunTrust Banks has a “Buy” rating and a $156.00 price objective on the stock. SunTrust Banks also issued estimates for athenahealth’s Q4 2017 earnings at $0.42 EPS, FY2018 earnings at $1.78 EPS and FY2019 earnings at $2.35 EPS.
A number of other brokerages have also recently issued reports on ATHN. ValuEngine raised athenahealth from a “sell” rating to a “hold” rating in a research report on Monday, July 24th. Evercore ISI reissued an “outperform” rating and issued a $163.00 target price (up from $155.00) on shares of athenahealth in a research report on Saturday, July 22nd. Cowen and Company cut athenahealth from an “outperform” rating to a “market perform” rating and upped their target price for the company from $127.00 to $133.00 in a research report on Monday, July 31st. Wells Fargo & Company decreased their target price on athenahealth from $190.00 to $155.00 and set an “outperform” rating for the company in a research report on Monday, October 23rd. Finally, Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $184.00 target price on shares of athenahealth in a research report on Friday, October 20th. Two investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $143.22.
TRADEMARK VIOLATION NOTICE: “Equities Analysts Set Expectations for athenahealth, Inc.’s FY2017 Earnings (ATHN)” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another website, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2017/11/12/suntrust-banks-comments-on-athenahealth-inc-s-fy2017-earnings-athn.html.
Shares of athenahealth (ATHN) opened at $124.54 on Friday. The stock has a market capitalization of $4,976.60, a PE ratio of 105.39, a P/E/G ratio of 5.00 and a beta of 1.57. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67. athenahealth has a 1 year low of $90.11 and a 1 year high of $158.66.
athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.06. The firm had revenue of $304.60 million during the quarter, compared to analysts’ expectations of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The business’s revenue was up 10.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.60 EPS.
In other athenahealth news, CEO Jonathan Bush sold 4,000 shares of the stock in a transaction on Friday, September 1st. The stock was sold at an average price of $139.77, for a total transaction of $559,080.00. Following the sale, the chief executive officer now owns 319,807 shares in the company, valued at approximately $44,699,424.39. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Jonathan D. Porter sold 300 shares of the stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $142.88, for a total value of $42,864.00. The disclosure for this sale can be found here. Insiders sold a total of 12,783 shares of company stock valued at $1,680,236 over the last ninety days. 3.20% of the stock is currently owned by company insiders.
Large investors have recently made changes to their positions in the business. Turner Investments LLC acquired a new stake in athenahealth during the 2nd quarter valued at $105,000. Bessemer Group Inc. grew its holdings in athenahealth by 13.7% during the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after buying an additional 113 shares during the last quarter. FNY Partners Fund LP grew its holdings in athenahealth by 1,900.0% during the 1st quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after buying an additional 950 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in athenahealth by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after buying an additional 84 shares during the last quarter. Finally, Seven Bridges Advisors LLC grew its holdings in athenahealth by 5.4% during the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock valued at $183,000 after buying an additional 67 shares during the last quarter.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Get a free copy of the Zacks research report on athenahealth (ATHN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.